← Back
$CPRX All transactions

CATALYST PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

158,454

Price

$0

Filed

Nov 24

Insider

Name

Miller Steve

Title

Chief Op. & Scientific Officer

CIK

0001402535

Roles

Officer

Transaction Details

Transaction Date

2025-11-20

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,457,963

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. | Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027, and 1/3rd on November 20, 2028. | Shares of common stock will be delivered to the Reporting Person upon vesting. | Derivative securities vest in three equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026, and 1/3rd on November 21, 2027. | Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on November 21, 2025.

Filing Info

Accession No.

0001161697-25-000420

Form Type

4

Issuer CIK

0001369568

Miller Steve's History

Date Ticker Type Value
2025-12-29 CPRX M
2025-12-29 CPRX M $0
2025-12-08 CPRX M
2025-12-08 CPRX M $0
2025-11-21 CPRX M
2025-11-21 CPRX M $0
2025-11-20 CPRX A $0
2025-11-20 CPRX A $0
2025-08-27 CPRX M $246K
2025-08-27 CPRX M $0

Other Insiders at CPRX (90d)

Insider Bought Sold Last
Russo Gregg
Chief HR Officer
2026-02-17